Internal Medicine · Pasadena, CA
NPI
1215925409
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2544 E Washington Blvd, Suite 3
Pasadena, CA, 91107
Phone (626) 798-1085
Groups this clinician bills Medicare through
Medicare paid, 2024
$157K
1,763 services
Medicare patients, 2024
360
Average age 78
Drug cost, 2024
$2.1M
19,470 prescriptions
Company payments, 2025
$1,109
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marina E Manvelyan was code 99214 (office e&m - established), 530 times for 269 patients. In total Marina E Manvelyan billed 1,763 services in 35 codes, and Medicare paid $157K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 530 | 269 | $115.89 | $61K |
| 99215 Office E&M - Established | Office | 224 | 159 | $156.31 | $35K |
| 99442 Telephone Services | Office | 118 | 81 | $76.92 | $9,077 |
| 96372 Injection Administration | Office | 106 | 41 | $13.35 | $1,415 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 89 | 31 | $0.98 | $87.48 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 87 | 87 | $22.82 | $1,985 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 85 | 85 | $22.83 | $1,940 |
| 99213 Office E&M - Established | Office | 81 | 66 | $83.71 | $6,780 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 74 | 74 | $151.85 | $11K |
| 93000 Electrocardiogram | Office | 54 | 50 | $13.18 | $712 |
| 93040 Electrocardiogram | Office | 52 | 48 | $11.95 | $621 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 44 | 37 | $254.62 | $11K |
| 90662 Vaccine Product | Office | 41 | 41 | $81.58 | $3,345 |
| G0008 Administration of influenza virus vaccine | Office | 41 | 41 | $35.02 | $1,436 |
| 99212 Office E&M - Established | Office | 13 | 13 | $53.42 | $695 |
By year: 2022 $119K for 1,736 services; 2023 $161K for 2,022 services; 2024 $157K for 1,763 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 33 | 29 | $3.41 | $113 |
| 82270 Immunoassay | 12 | 12 | $4.29 | $51.48 |
Medicare prescription drug claims, 2024
In 2024, the drug Marina E Manvelyan prescribed most often to Medicare patients was Levothyroxine Sodium, with 810 prescriptions and refills. In total Marina E Manvelyan wrote 19,470 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 810 | 1,469 | 153 | $9,591 |
| Amlodipine Besylate Generic | 668 | 1,178 | 143 | $2,929 |
| Atorvastatin Calcium Generic | 637 | 1,178 | 137 | $5,035 |
| Gabapentin Generic | 616 | 839 | 112 | $9,068 |
| Rosuvastatin Calcium Generic | 567 | 992 | 111 | $5,861 |
| Metformin Hcl Generic | 458 | 763 | 82 | $1,874 |
| Pantoprazole Sodium Generic | 432 | 720 | 101 | $3,901 |
| Losartan Potassium Generic | 396 | 748 | 86 | $3,107 |
| Carvedilol Generic | 372 | 578 | 65 | $2,467 |
| Furosemide Generic | 362 | 564 | 79 | $1,450 |
| Escitalopram Oxalate Generic | 280 | 463 | 60 | $2,435 |
| Omeprazole Generic | 269 | 444 | 60 | $3,184 |
| Potassium Chloride Generic | 246 | 352 | 48 | $3,449 |
| Eliquis Apixaban | 244 | 316 | 37 | $171K |
| Famotidine Generic | 227 | 322 | 50 | $1,812 |
Brand drugs: 3,122 claims; generic drugs: 16,162 claims; opioid claims: 302.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marina E Manvelyan $1,109 ($1,109 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbott Laboratories with $196.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 2 | $196 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $144 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $89.22 |
| Lundbeck LLC | 4 | $84.53 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $81.05 |
| Abbvie Inc. ABBV | 3 | $66.79 |
| Amgen Inc. AMGN | 3 | $62.63 |
| DePuy Synthes Sales Inc. JNJ | 1 | $51.89 |
| GlaxoSmithKline, LLC. GSK | 2 | $47.73 |
| Pfizer Inc. PFE | 2 | $46.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.